Kesh A

Founder, Apex BioAdvisors

Kesh A. is the founder of Apex BioAdvisors, a biotech strategy advisory firm built to be a long-term strategic partner to CEOs, senior leadership teams, and boards. Drug development and company-building unfold over years, with critical inflection points along the way, and Apex is designed to provide continuity across the decisions that shape a company’s trajectory.

Before founding Apex, Kesh led biotech investing at the institutional and family office levels, held senior roles in biotech equity research and investment banking, advised on strategic transactions, and participated in board governance for private companies. This background gives Apex a practical understanding of how therapeutics companies operate and how they are evaluated by investors, partners, boards, and strategic counterparties.

Sitting at the intersection of science, strategy, and capital markets, Kesh draws on his medical education at Yale, 15 years of scientific research experience, biotech investing experience, and strategic finance judgment to help leadership teams translate scientific, clinical, market, and financing complexity into clearer strategic priorities and better decision-making.

Apex supports public and private therapeutics companies across clinical- and investor-informed corporate strategy, competitive intelligence, portfolio optimization, partnering and business development preparation, financing readiness, and external positioning.

For strategic advisory inquiries, contact us at kesh@apexbioadvisors.com